1. Home
  2. NRBO vs KIRK Comparison

NRBO vs KIRK Comparison

Compare NRBO & KIRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRBO
  • KIRK
  • Stock Information
  • Founded
  • NRBO N/A
  • KIRK 1966
  • Country
  • NRBO United States
  • KIRK United States
  • Employees
  • NRBO N/A
  • KIRK N/A
  • Industry
  • NRBO Biotechnology: Pharmaceutical Preparations
  • KIRK Diversified Commercial Services
  • Sector
  • NRBO Health Care
  • KIRK Miscellaneous
  • Exchange
  • NRBO Nasdaq
  • KIRK Nasdaq
  • Market Cap
  • NRBO 27.9M
  • KIRK 28.2M
  • IPO Year
  • NRBO N/A
  • KIRK 2002
  • Fundamental
  • Price
  • NRBO $2.42
  • KIRK $1.61
  • Analyst Decision
  • NRBO Strong Buy
  • KIRK Buy
  • Analyst Count
  • NRBO 1
  • KIRK 2
  • Target Price
  • NRBO $10.00
  • KIRK $4.50
  • AVG Volume (30 Days)
  • NRBO 36.9K
  • KIRK 182.7K
  • Earning Date
  • NRBO 11-07-2024
  • KIRK 11-29-2024
  • Dividend Yield
  • NRBO N/A
  • KIRK N/A
  • EPS Growth
  • NRBO N/A
  • KIRK N/A
  • EPS
  • NRBO N/A
  • KIRK N/A
  • Revenue
  • NRBO N/A
  • KIRK $460,353,000.00
  • Revenue This Year
  • NRBO N/A
  • KIRK N/A
  • Revenue Next Year
  • NRBO N/A
  • KIRK $0.90
  • P/E Ratio
  • NRBO N/A
  • KIRK N/A
  • Revenue Growth
  • NRBO N/A
  • KIRK N/A
  • 52 Week Low
  • NRBO $2.08
  • KIRK $1.39
  • 52 Week High
  • NRBO $6.75
  • KIRK $3.54
  • Technical
  • Relative Strength Index (RSI)
  • NRBO 40.83
  • KIRK 44.38
  • Support Level
  • NRBO $2.30
  • KIRK $1.55
  • Resistance Level
  • NRBO $2.50
  • KIRK $1.63
  • Average True Range (ATR)
  • NRBO 0.23
  • KIRK 0.09
  • MACD
  • NRBO -0.01
  • KIRK 0.00
  • Stochastic Oscillator
  • NRBO 24.75
  • KIRK 38.33

About NRBO NeuroBo Pharmaceuticals Inc.

NeuroBo Pharmaceuticals Inc is a clinical-stage biotechnology company focused predominantly on developing and commercializing novel pharmaceuticals to treat cardiometabolic diseases. The company has two primary programs focused on the treatment of metabolic dysfunction-associated steatohepatitis (MASH), and obesity. Its product pipeline includes DA-1241 which is a novel G-Protein-Coupled Receptor 119 (GPR119) and DA-1726 which is a novel oxyntomodulin (OXM) analog. The company also has four legacy therapeutics programs designed to impact a range of indications in viral, neurodegenerative, and cardiometabolic diseases: ANA001, NB-01, NB-02, and Gemcabene.

About KIRK Kirkland's Inc. COMMONSTOCK

Kirkland's Inc is a specialty retailer of home decor and gifts in the United States. The company stores provide various merchandise, including holiday decor, value pricing, and a stimulating in-store and online environment that provides customers with a brand experience. The company stores also offer an assortment of holiday merchandise in seasonal periods, as well as items that are suitable for gift-giving.

Share on Social Networks: